Thomas Richard Myers - 18 Jun 2021 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Role
Chief Operating Officer
Signature
/s/ Thomas Myers
Issuer symbol
PURE
Transactions as of
18 Jun 2021
Net transactions value
$0
Form type
4
Filing time
22 Jun 2021, 20:25:48 UTC
Next filing
04 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PURE Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 18 Jun 2021 Common Stock 100,000 $0.4500 Direct F1
transaction PURE Stock Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 18 Jun 2021 Common Stock 125,000 $0.4500 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023.
F2 The option shares shall vest and become exercisable in four equal installments on September 18, 2021, December 18, 2021, March 18, 2022 and June 18, 2022.